Pivoting Fearlessly: Startup to Global Enterprise

Recording: Pivoting Fearlessly: Startup to Global Enterprise, Date TBA

Moderna President, Stephen Hoge, M.D. and FORTUNE's Editor-in-Chief, Alyson Shontell, will discuss Moderna’s meteoric rise from R&D-focused startup to global commercial enterprise. The public witnessed the company’s decade-long investment in messenger RNA (mRNA) pay off, as it led to development of one of the world’s first COVID-19 vaccines during the worldwide health crisis. For entrepreneurs and leaders grappling with challenges of scale, Hoge will discuss the implications and lessons learned for Moderna’s business, its people and culture, the biotech industry, and the future of medicine.

Programming descriptions are generated by participants and do not necessarily reflect the opinions of SXSW.

Alyson Shontell

Fortune Media

This event will be in person

Details

Primary Entry:
Music Badge
Platinum Badge
Film Badge
Interactive Badge
Format:

Presentation

Type:

Session

Track:

Startups

Level:

Intermediate

Resources:

Presentation